4//SEC Filing
Stellar Biotechnologies, Inc. 4
Accession 0001144204-16-140709
$EDSACIK 0001540159operating
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:00 PM ET
Size
5.4 KB
Accession
0001144204-16-140709
Insider Transaction Report
Form 4
NIFFENEGGER KATHI
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2016-12-20+10,000→ 10,000 totalExercise: $2.03Exp: 2023-12-20→ Common Shares (10,000 underlying)
Footnotes (1)
- [F1]Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third immediately, as to one-third on December 20, 2017 and as to the remaining one-third on June 20, 2018.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001540159
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 5:00 PM ET
- Size
- 5.4 KB